The development of a novel dual-targeting peptide vaccine therapy in patients with resected pancreatic cancer.
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2017
At a glance
- Drugs OCV C01 (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 07 Jun 2016 18-month results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 24 Nov 2013 Status changed from not yet recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 06 Jun 2012 New trial record